We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Essex Property Trust
ESS
$18.5B
| $14.6M | 0.04% |
72,800
-2,400
| -3% | -$523K |
|
452
Truist Financial
TFC
$64B
| $14.6M | 0.04% |
383,527
-836,498
| -69% | -$31.5M |
|
453
Darden Restaurants
DRI
$24.4B
| $14.5M | 0.04% |
144,200
-4,700
| -3% | -$390K |
|
454
J.M. Smucker
SJM
$12.8B
| $14.4M | 0.04% |
124,927
+900
| +0.7% | +$100K |
|
455
Alliant Energy
LNT
$18B
| $14.3M | 0.04% |
276,790
+5,224
| +2% | +$273K |
|
456
StepStone Group
STEP
$3.82B
| $14.3M | 0.04% |
+536,422
| New | +$13.7M |
|
457
Axsome Therapeutics
AXSM
$10.9B
| $14.3M | 0.04% |
200,000
| – | – |
|
458
W.W. Grainger
GWW
$60.2B
| $14M | 0.04% |
+39,371
| New | +$13.6M |
|
459
Kinder Morgan
KMI
$68.7B
| $14M | 0.04% |
1,135,100
-1,070,600
| -49% | -$14.9M |
|
|
TIF
460
DELISTED
Tiffany & Co.
TIF
| $13.8M | 0.03% |
119,354
-3,900
| -3% | -$474K |
|
461
Expeditors International
EXPD
$23.2B
| $13.8M | 0.03% |
152,430
+49,830
| +49% | +$4.24M |
|
|
BLD
462
DELISTED
TopBuild
BLD
| $13.8M | 0.03% |
+80,626
| New | +$11.6M |
|
463
Expedia Group
EXPE
$37.3B
| $13.7M | 0.03% |
149,000
-4,900
| -3% | -$441K |
|
464
Jacobs Solutions
J
$17B
| $13.7M | 0.03% |
177,991
-5,682
| -3% | -$415K |
|
|
GRTX
465
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $13.6M | 0.03% |
1,509,500
| – | – |
|
466
Waters Corp
WAT
$39.9B
| $13.6M | 0.03% |
69,343
+62,700
| +944% | +$13M |
|
467
Fortune Brands Innovations
FBIN
$6.06B
| $13.5M | 0.03% |
182,773
-1,290,657
| -88% | -$86.3M |
|
468
Avantor
AVTR
$9.19B
| $13.5M | 0.03% |
600,000
-200,000
| -25% | -$4.16M |
|
469
Cirrus Logic
CRUS
$6.26B
| $13.5M | 0.03% |
+200,000
| New | +$12.5M |
|
470
T. Rowe Price
TROW
$24.3B
| $13.4M | 0.03% |
104,730
-108,200
| -51% | -$14.3M |
|
|
CTLT
471
DELISTED
CATALENT, INC.
CTLT
| $13.4M | 0.03% |
+155,900
| New | +$13.2M |
|
472
International Flavors & Fragrances
IFF
$21.9B
| $13.3M | 0.03% |
108,996
-14,900
| -12% | -$1.85M |
|
473
AXIS Capital
AXS
$7.55B
| $13.2M | 0.03% |
+300,000
| New | +$13.1M |
|
|
LEAP.U
474
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
| $13M | 0.03% |
+1,000,000
| New | +$12.7M |
|
475
FIVE9
FIVN
$2.6B
| $13M | 0.03% |
+100,000
| New | +$12M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.